Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Off The Hook Yachts Announces Share Buyback Plan
-
NewtekOne, Inc. Posts Investor Day Presentation and Provides 2026 EPS Guidance Range of $2.15-$2.55
-
Form 8.3 - Avadel Pharmaceuticals plc
-
More Than a North American Debut: DDPAI Brings a Vision Beyond Dashcams to CES 2026
-
Telos Corporation Renews $5.4M Cyber GRC Engagement with Leading Global Technology Company
-
Alpha Modus Advances AlphaCash Rollout, Highlighting Scalable Path to Embedded Financial Access in Grocery and Convenience Retail
-
CORRECTING and REPLACING – BitMEX Report Finds Crypto Perpetuals Enter Post-Yield Era
-
PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options
-
Flare Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Illumina and PREMIA partner to expand clinical access to CGP in Asia
-
AXIL Brands, Inc. Reports Second Quarter Fiscal Year 2026 Financial Results
-
Colabor Group Inc. Files Application for Creditor Protection Under the CCAA
-
CorMedix Therapeutics Announces Leadership and Board Updates
-
MannKind Provides Business Updates and 2026 Growth Drivers
-
STARTRADER Begins 2026 as Official Partner of the NBA
-
SEO As Easy As Using a Toaster: Tech Startup Replaces Complex Analytics with Simplicity and a Ranking Guarantee
-
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
-
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
-
King Copper Discovery Announces Private Placement
-
NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant
-
IP Strategy Publishes Monthly Validator & Ecosystem Update
-
Beyond Oil Appoints Dganit Kramer to Advisory Board, Strengthening Commercial Execution and Governance
-
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib
-
RESTEM Provides Corporate Update and Announces Strategic Priorities for 2026
-
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease
-
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
-
Kepler Fusion Technologies Unveils New CEO Interview Highlighting Progress and Vision for Its Proprietary Fusion Power Platform
-
XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor
-
First Orion Partners with Deutsche Telekom to Launch Branded Calling to Combat Call Fraud in Germany
-
CCC Intelligent Solutions Introduces OEM Repair Certification Management Solution
-
Silicon Valley Acquisition Corp. Announces Closing of Over-Allotment Option in Connection with Its Initial Public Offering
-
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
-
LPL Financial Welcomes Rand, Williams & Associates, LLC
-
Zacatecas Silver Provides Corporate Update for 2026 and Highlights Upcoming Drill Program at Silver Project
-
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia
-
Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
-
Northern Technologies International Corporation Reports Financial Results for First Quarter Fiscal 2026
-
Pan American Energy Reviews 2025 Work and Outlines 2026 Exploration Strategy
-
AmpliTech Group Appoints Professor Tommaso Melodia To Its Board of Advisors to Support Strategic Growth Across ORAN Architectures and AI-native Wireless Networks
-
Made In Cookware Partners with Light Labs for Third-Party Testing to Advance Cookware Safety and Transparency
-
ORYZON to Participate in Upcoming Events in January
-
StoneX Announces Strategic Partnership with Enhanced Digital Group and Leads Series A Funding Round
-
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, AMYY, TQQY, AZYY, YSPY, MTYY, PLYY, HOYY, SMYY, BBYY, FBYY, IOYY, MAAY, NUGY, SEMY, QBY, RGYY, HMYY and RT
-
InflaRx Announces Strategy Focused on Capital-Efficient Execution with Izicopan and Near-Term Value Creation
-
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
-
NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway
-
Texxon Holding Limited Completes Key Safety and Regulatory Milestones for 600,000-Ton Polystyrene Project
-
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
-
LiveOne (NASDAQ: LVO) Achieves Major Milestones, Closes $65M+ in Partnership Revenue
-
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
